DM Clinical Research - Philadelphia
DM Clinical Research - Philadelphia
Philadelphia, Pennsylvania, United States7 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Learn About the Safety and Immune Responses of RSVpreF in Older Adults | Adult; Healthy Participants | Recruiting | Phase 3 | 2026-10-09 | NCT07819097 | |
| To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment | Chronic Disease, Disease Attributes, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bronchial disorder, bronchitis, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, respiratory system disorder, respiratory tract infectious disorder | Recruiting | Phase 2 | 2026-09-30 | NCT07684820 | |
| A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19) | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Active, not recruiting | Phase 4 | 2026-09-28 | NCT07266558 | |
| A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older | Clostridoides Difficile Associated Disease | Recruiting | Phase 3 | 2026-09-09 | NCT07282665 | |
| A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to 55-Year-Old Healthy Participants | DNA Virus Infections, Epstein-Barr virus infection, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Tumor Virus Infections, hematologic disorder, immune system disorder, immunoproliferative disorder, infectious mononucleosis, leukocyte disorder, lymphatic system disorder, lymphoproliferative syndrome, viral infectious disease | Active, not recruiting | Phase 1 | 2026-08-11 | NCT05831111 | |
| Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Immunobridging to Adults 18-49 | Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, lung disorder, pneumococcal infection, pneumonia, respiratory system disorder, respiratory tract infectious disorder, streptococcal infection | Active, not recruiting | Phase 3 | 2026-05-15 | NCT07284654 | |
| A Study to Learn About mRNA Vaccines Against Influenza in Adults | Infections, RNA Virus Infections, influenza, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease | Recruiting | Phase 2 | 2026-05-06 | NCT07431853 |